EX-23.1 3 tmb-20221231xex23d1.htm EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the registration statements (No. 333-257579 and No. 333-263990) on Form S-8 and in the registration statement (No. 333-266883) on Form S-3 of our report dated March 29, 2023, with respect to the consolidated financial statements of Aerovate Therapeutics, Inc.

/s/ KPMG LLP

San Diego, California

March 29, 2023